Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 38.80
-0.10 (-0.26%)
Sep 23, 2026, 3:38 PM IDT
Nextage Therapeutics Revenue
Nextage Therapeutics had revenue of 268.00K ILS in the half year ending June 30, 2026, a decrease of -82.41%. This brings the company's revenue in the last twelve months to 2.51M, down -17.77% year-over-year. In the year 2025, Nextage Therapeutics had annual revenue of 3.60M with 11.57% growth.
Revenue (ttm)
2.51M
Revenue Growth
-17.77%
P/S Ratio
12.55
Revenue / Employee
139.56K
Employees
18
Market Cap
31.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.60M | 373.00K | 11.57% |
| Dec 31, 2024 | 3.23M | -4.40M | -57.71% |
| Dec 31, 2023 | 7.63M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 91.00K | -100.00K | -52.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Rafa Laboratories | 459.86M |
| BrainsWay | 180.82M |
| Together Pharma | 99.94M |
| Identi Healthcare | 12.44M |
| BioLineRx | 4.15M |
| Merchavia Holdings and Investments | 77.00K |